Agencies | Governor
Virginia Regulatory Town Hall
Virginia Racing Commission
Virginia Racing Commission
Medication [11 VAC 10 ‑ 180]
This action is exempt from the executive branch review process.
To amend regulations pertaining to medication in racehorses.
General Information
Action Summary The amendments adopt four new substantive provisions in Medication (11 VAC 10-180-10 et seq.). The provisions are (i) the possessing or administering Erythropietin or any analogous substance is prohibited, (ii) prohibiting the use of "shockwave therapy" devices on racehorses ten days prior to a race, (iii) treating racehorses three hours or less prior to post time, and (iv) restricting the levels of carbon dioxide concentrations in post-race testing.
Chapters Affected Only affects this chapter.
Exempt from APA Yes, this action is exempt from Article II of the APA and executive branch review.
Exempt Citation: 2.2-4002 (B) (23)
RIS Project No project yet assigned to this action
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
2229 Final Stage complete. This regulation became effective on 03/31/2003.
Contact Information
Name / Title: Kimberly Mackey  / Regulatory Coordinator
Address: 5707 Huntsman Road
Suite 201-B
Richmond, VA 23250
Email Address:
Phone: (804)966-7406    FAX: ()-    TDD: ()-

This person is the primary contact for this board.